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A B S T R A C T
Purpose: To determine fetal doses in different stages of pregnancy in three common computed tomography (CT)
examinations: pulmonary CT angiography, abdomino-pelvic and trauma scan with Monte Carlo (MC) simula-
tions.
Methods: An adult female anthropomorphic phantom was scanned with a 64-slice CT using pulmonary angio-
graphy, abdomino-pelvic and trauma CT scan protocols. Three different sized gelatin boluses placed on the
phantom’s abdomen simulated different stages of pregnancy. Intrauterine dose was used as a surrogate to a dose
absorbed to the fetus. MC simulations were performed to estimate uterine doses. The simulation dose levels were
calibrated with volumetric CT dose index (CTDIvol) measurements and MC simulations in a cylindrical CTDI
body phantom and compared with ten point doses measured with metal-oxide-semiconductor field-effect-tran-
sistor dosimeters. Intrauterine volumes and uterine walls were segmented and the respective dose volume his-
tograms were calculated.
Results: The mean intrauterine doses in different stages of pregnancy varied from 0.04 to 1.04 mGy, from 4.8 to
5.8 mGy, and from 9.8 to 12.6 mGy in the CT scans for pulmonary angiography, abdomino-pelvic and trauma CT
scans, respectively. MC simulations showed good correlation with the MOSFET measurement at the measured
locations.
Conclusions: The three studied examinations provided highly varying fetal doses increasing from sub-mGy level
in pulmonary CT angiography to notably higher levels in abdomino-pelvic and trauma scans where the fetus is in
the primary exposure range. Volumetric dose distribution offered by MC simulations in an appropriate an-
thropomorphic phantom provides a comprehensive dose assessment when applied in adjunct to point-dose
measurements.
1. Introduction
A developing fetus has a high sensitivity to ionizing radiation [1,2],
and therefore, monitoring and limiting ionizing radiation exposure of
an expecting mother bears a great importance. However, in certain si-
tuations, a computed tomography (CT) scan during pregnancy can be
justified. The most common indications for CT during pregnancy are
suspected pulmonary embolism, suspected appendicitis and trauma [3].
In these situations, the embryo or fetus can be fully or partially in the
primary X-ray beam or in its immediate vicinity. It is desirable to know
the absolute fetal dose in order to assess the subsequent cancer risk to
the unborn child prior to a CT examination. This information is es-
sential in the study justification and helpful in mitigating the mother’s
possible concerns about the radiation effects on the developing fetus.
The fetal dose cannot be measured directly inside the patient,
although surface measurements could be made in vivo. However, the
surface measurements do not give extensive information about the ac-
tual dose distribution inside the patient. The fetal dose can be esti-
mated, for example, by phantom measurements with different types of
dosimeters or by Monte Carlo (MC) simulations. Both methods require a
model of a pregnant patient, representing the studied pregnancy stage.
For that purpose, a commercially available female phantom can be
modified to represent a pregnant woman. Furthermore, a fetal volume
has to be defined for the corresponding anthropomorphic pregnancy
model in order to determine the fetal dose. In experimental dose
measurements, it is possible to obtain only discrete point doses whereas
MC simulations provide a full 3D dose distribution. On the other hand,
the fidelity of the MC is dependent on the assumptions and approx-
imations in the simulation parameters and the underlying interaction
model.
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The uterine volume increases remarkably during pregnancy, and a
large variation between individuals exists. Some studies have in-
vestigated the growth of the uterine volume and the uterine wall
thickness during pregnancy [4–6], but these have tended to focus only
on certain pregnancy stages and not to cover the whole pregnancy. The
ICRP Publication 89 [7] provides reference values for the increase in
mass of the fetus, placenta, amniotic fluid and uterus at 10, 20, 30 and
38 weeks of pregnancy along with the mass of a pregravid uterus and
the corresponding densities.
Some previous studies have concentrated on using MC simulations
to determine fetal doses in radiological examinations [8–13]. The MC
programs or codes used in these previous studies were SIERRA [8],
WinODS [9], MCNPX [10,13], MCNP [11], ImpactMC [12] and EGSnrc
[14]. In these studies, the stages of pregnancy ranged from early ge-
station (7 weeks) to late gestation (37 weeks), focusing usually on
certain pregnancy stages. Most of these publications focused on CT
examinations of the chest, abdomen and pelvis. A MC based method
utilizing stylized mathematical phantoms to estimate the fetal dose in
all stages of gestation and from any multi-detector CT examination of
the trunk has also been developed [11]. Some of the very recent pub-
lications have concentrated on comparing different methods for esti-
mating radiation dose to the conceptus [14] and comparing dosimetric
and MC calculation results [15]. It has also been noticed that there is a
lack of knowledge of fetal dosimetry in the imaging of pregnant women,
which may lead to underestimation or overestimation of radiation dose
and cancer risk [16–18]. The previous studies reporting the dose to the
fetus have used either dose measurements or MC simulations, but there
are few that combine them both.
The aim of this study was to determine absorbed fetal doses in
different pregnancy stages (12, 20, 28 and 38 weeks) by using MC si-
mulations and MOSFET measurements in order to validate the MC
package used for the phantom geometries of this study. This approach
was selected in order to achieve a comprehensive dose assessment with
the volumetric dose distribution offered by MC simulations applied in
conjunction to point-dose measurements. The MC simulation results for
fetal dose were calibrated by reference pencil ionization chamber
measurements and MC simulations in a cylindrical CT dose index
(CTDI) body phantom. Pregnant female phantom geometries were
achieved by modifying a physical anthropomorphic phantom. Three
most common CT examinations during pregnancy were studied: pul-
monary angiography, abdomino-pelvic and trauma. The intrauterine
dose was used as a surrogate to a dose absorbed to the fetus.
2. Materials and methods
2.1. Dose measurements
The dose measurements in an anthropomorphic adult female
phantom (CIRS ATOM 702-D, Norfolk, USA) were performed in a pre-
vious study with metal-oxide-semiconductor field-effect transistor
(MOSFET) dosimeters [19]. A 64-MDCT GE LightSpeed VCT scanner
(GE Healthcare, Milwaukee, WI, USA) was used in this study. Ten
MOSFET dosimeters were used and dose values were registered using a
mobileMOSFET 2.4.1. Dose Verification System (TN-RD-70-W, Best
Medical, Canada). CT protocols for the four pregnancy stages were
trauma, low-dose abdomino-pelvic and pulmonary angiography. The
scan parameters are shown in Table 1. The pitch and detector colli-
mation were set to 1.375 and 64 × 0.625 mm, respectively. ASiR
(adaptive statistical iterative reconstruction) level of 30% and a dose
reduction option of 30% were used. In all three scan protocols, the tube
current modulation (TCM) settings were according to clinical patient
scans and the scan field of view (SFOV) was adjusted for a large body.
The trauma CT scans resampled from 0.625 mm to 2.5 mm slice
thickness were used as the MC geometries. Slice resampling was done in
order to enable the simulations with existing computer memory capa-
city.
In order to obtain absolute dose values, calibration measurements
were performed for the ten MOSFETs using a pencil ionization chamber
(RaySafe Xi, Unfors RaySafe AB, Billdal, Sweden) as the reference do-
simeter. This was done as in-air measurements at the scanner isocenter
for both tube voltages (100 and 120 kVp) used in this study.
The method used to measure beam dose-profile across the axial scan
plane to determine bowtie filter thickness across the axial scan plane for
the large body SFOV corresponds to previously published static X-ray
tube method [20]. The dose values were measured with pencil ioniza-
tion chamber at 2 cm intervals in air to acquire the dose profile across
the beam in horizontal direction, with the tube fixed in the upright
position of the gantry. The bowtie filter thicknesses were calculated
based on the linear attenuation coefficients corresponding to the mean
photon energy and the density of Aluminium (Al).
The accuracy of the bowtie model used in this study was verified by
comparing pencil ionization chamber measurements and MC simulation
results in the center and periphery positions of a cylindrical CTDI body
phantom. The scanning parameters in the measurements were set ac-
cording to the annual CTDI measurements protocol, and the same
parameters were used in the MC simulations, including bowtie thick-
ness data and simulated X-ray spectrum (Spekcalc 2.0, see Section 2.3)
which corresponds to the methodology in previous publication [20].
The MC simulations were performed by using CT data of the body
phantom, and the CTDI calculation option in the MC simulation pro-
gram.
2.2. Organ segmentation
Intrauterine volumes and uterine walls were segmented from the CT
images of the female phantom in different pregnancy stages. The ab-
solute volumes were derived from the values presented in the ICRP
Publication 89 [7]. The intrauterine volumes included fetus, placenta
and amniotic fluid. The remaining exterior part of the volume was
designated as uterine wall. The total uterine volume is the intrauterine
volume and the uterine wall volume. This approach was selected in
order to examine the deviation of the doses the slight volume change of
the uterus and in order to evaluate the effect of uncertainty of the
uterine wall volume variability which can be taken into account in the
total uncertainty evaluation. The pregnancy stages and the corre-
sponding intrauterine volumes and uterine wall volumes are shown in
Table 2. According to the phantom manufacturer, the phantom was
made of tissue-equivalent epoxy resins with the following densities:
bone tissue (1.60 g/cm3), soft tissue (1.05 g/cm3), spinal cord (1.07 g/
cm3), spinal disks (1.15 g/cm3) and lungs (0.21 g/cm3). The different
stages of pregnancy were constructed with home-made gelatin boluses
by mixing water and gelatin in a heat bath and casting a bolus in a
spherical mold with varying spherical segment volumes for 20, 28 and
38 weeks of pregnancy. At 12 weeks of pregnancy, no bolus was used.
Table 1
The scan parameters used in the three CT protocols for the anthropomorphic phantom in
the four studied pregnancy stages: 12, 20, 28 and 38 weeks. Volumetric CT dose index
(CTDIvol) and dose length product (DLP) values were reported by the scanner.
Trauma Abdomino-pelvic Pulmonary
angiography
Tube voltage (kVp) 120 120 100
Rotation time (s) 0.5 0.5 0.4
Scan length (mm) 940 324 272
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The gelatin boluses had a contrast of 7 ± 22 HU (average ± 1 stan-
dard deviation, SD), according to the 120 kVp scan. The bolus sizes and
uterine wall segmentations for pregnancy weeks 12, 20, 28 and 38 are
presented in Fig. 1. The bolus volumes were 6.5, 18.0, and 40.6 dl for
the pregnancy stages of 20, 28 and 38 weeks, respectively. Phantom
circumferences were approximately 77 cm, 83 cm, 88 cm and 94 cm for
12, 20, 28 and 38 weeks, respectively. These were measured just above
the ilium where the boluses' cross sections were at their largest. Phan-
tom's waist was 69 cm at minimum. The delineations were adjusted to
fulfill the ICRP references volumes and to follow the anthropomorphic
phantom geometry, including the pregnancy stage specific bolus vo-
lume and shape. The intrauterine dose was used as a surrogate to a dose
absorbed to the fetus.
2.3. Dose simulations
ImpactMC software (GPU version 1.4.0.0, 2014, ImpactMC, Vamp
GmbH, Germany) was used for the MC dose simulations. The program
allows an adaptation to scanner-specific irradiation geometries and
individual patient or phantom characteristics. Prior to the MC simula-
tion, the X-ray spectra applied in the CT scans were simulated by using
information from the vendor specifications (tube type, half value layer,
anode material and filtration) and Spekcalc 2.0 program [21]. The
bowtie thickness data and simulated X-ray spectrum were then used
as an input for the MC simulations, together with the anthropomorphic
phantom CT voxel data, CT examination specific longitudinal scan
ranges and tube current values based on the data. The TCM accounted
for tube current variations in z-axis direction, and values were collected
from the DICOM headers of the phantom CT slices in the three scan
Table 2
The pregnancy stages and the corresponding uterine wall and intrauterine volumes.





† Linearly interpolated from the values reported in the ICRP publication 89 for 10, 20,
30 and 38 weeks [7].
Fig. 1. Upper image: The sagittal views of the anthropomorphic female phantom with gelatin boluses and the uterine wall segmentations representing pregnancy stages of 12 (A), 20 (B),
28 (C) and 38 (D) weeks. Lower image: The phantom and the gelatin boluses at pregnancy stages of 20 (B), 28 (C) and 38 (D) weeks.
Table 3
MC parameters in ImpactMC.
Property Value
Focus to center of rotation distance (mm) 541
Fan angle (rad) 0.9
Number of rotations1/2/3 5/6/17
Rotation time (s)1/2/3 0.4/0.5/0.5
Start angle (rad) 0.0
Table increment (mm) 55
Total beam collimation (mm) 40
X-ray tube voltage (kVp) 100/120/120
Break energy (keV) 10.0
Maximum number of photons 5E+09
Number of interactions 10
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protocols. Furthermore, symmetric collimation, positive rotation di-
rection and spiral scanning mode was used in the simulations. The main
MC simulation parameters are shown in Table 3. The time per simu-
lation was approximately 1.5 h for the used maximum number of
photons, 5E+09.
In this study, MC simulation results for fetal dose were calibrated by
pencil ionization chamber measurements and MC simulations in a cy-
lindrical CTDI body phantom. Mean MC doses were recorded at
MOSFET positions using 15-mm-diameter spherical volumes-of-interest
(VOIs). The VOI size was greater than the dosimeter active volume and
was selected to ensure adequate statistics and to avoid confounding
effects from air and metal at the dosimeter sites. The voxels containing
metal were excluded from the dose VOI. The MC results were scaled
according to the CTDIvol-meas/CTDIvol-MC ratio to obtain the final si-
mulated dose maps. The MC simulation results and MOSFET measure-
ment results were compared for more comprehensive dosimetric eva-
luation. An absolute dose distribution was acquired from each
simulation. Linear fit with forced intercept at the origin was used in the
comparison between the MC simulation and MOSFET measurement
points.
Absorbed doses to the intrauterine volumes and uterine walls were
determined by co-registering the 3D dose maps with the segmented
volumes. Integral dose volume histograms, dose distribution quartile
values and mean values were determined from each pregnancy stage,
from each scan protocol and for both intrauterine volume and uterine
wall volume. Source CT image data which was used in the simulations
included local inhomogeneities due to small air cavities on the bolus-
phantom interface and due to MOSFET dosimeter structures. The cor-
responding simulated voxel dose values were not regarded as re-
presentative of the actual tissue dose and therefore those voxel doses
were omitted in the overall volumetric dose determination.
3. Results
3.1. Dose measurements and simulations
CTDI body phantom MC simulations resulted in 8.5% and 6.1%
lower CTDIvol-values compared to pencil chamber dosimeter measure-
ments when 120 kVp and 100 kVp tube voltages, respectively, 40 mm
collimation and large SFOV were used. The CTDIvol-meas/CTDIvol-MC
ratios were 1.093 and 1.065 for 120 kVp and 100 kVp, respectively.
CTDIvol displayed by the scanner console divided by the measured air
kerma at the isocenter were 0.36 and 0.33 for 120 kVp and 100 kVp,
respectively, 40 mm total beam collimation (projected to scan iso-
center) and large SFOV.
MC dose map scaling factors obtained from linear fits with MOSFET
measurements ranged from 0.99 to 1.05 for trauma, from 0.91 to 1.04
for abdomino-pelvic and from 0.44 to 0.52 for pulmonary angiography
protocols. The results for trauma, abdomino-pelvic and pulmonary
angiography protocols are shown in Fig. 2 with linear regression lines
fitted to all MOSFET measurement points inside the phantom, with the
corresponding scaling factors and coefficients of determination, R2.
3.2. Uterine doses
Tables 4–6 present the simulated and measured mean doses in dif-
ferent pregnancy stages in pulmonary angiography, abdomino-pelvic
and trauma CT scan protocols, respectively. Integral dose volume his-
tograms corresponding to the studied pregnancy stages and scan pro-
tocols are presented in Fig. 3. Box-and-whisker plots showing the 2nd
and 98th percentiles, the first and third quartiles and median dose le-
vels for each pregnancy stage and scan protocol are shown in Fig. 4.
Absorbed doses to the intrauterine volumes were the greatest in the
trauma CT scan, whereas the intrauterine doses were lowest in the
pulmonary CT angiography scan.
3.3. Uncertainty calculations
In the MC simulations, the relative statistical uncertainty of voxel
dose (SD/mean) in uterine region was approximately 10% in the ab-
dominal and trauma scans, and considerably higher (> 100%) in the
Fig. 2. Absorbed dose at MOSFET dosimeter positions in trauma abdomino-pelvic (Abd.)
and pulmonary angiography (PA) protocols as a function of the MC simulations results at
the same positions.
Table 4
The pregnancy stages and the corresponding simulated mean doses to the intrauterine
volumes and total uterine volumes in the pulmonary angiography CT scan protocol.







Fetal dose in MOSFET
measurements (mGy)
[19]
12 0.04 0.04 0.03
20 0.09 0.09 0.08
28 0.27 0.29 0.14
38 1.04 1.13 0.22
Table 5
The pregnancy stages and the corresponding simulated mean doses to the intrauterine
volumes and total uterine volumes in the low-dose abdomino-pelvic CT scan protocol.







Fetal dose in MOSFET
measurements (mGy)
[19]
12 5.2 5.1 4.7
20 5.8 5.8 5.5
28 4.9 4.9 4.9
38 4.8 4.8 5.1
Table 6
The pregnancy stages and the corresponding simulated mean doses to the intrauterine
volumes and total uterine volumes in the trauma CT scan protocol. Corresponding







Fetal dose in MOSFET
measurements (mGy)
[19]
12 11.3 11.3 10.6
20 12.6 12.6 11.2
28 10.3 10.3 10.1
38 9.8 9.9 10.7
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pulmonary angiography scans where uterus volume is out of the pri-
mary scan region and receives only scattered radiation. However, the
uterus or any practical (macroscopic) volume of interest contain very
large amount of voxels. Therefore, according to the standard error of
the mean, a reasonable upper estimate of the statistical uncertainty of
the mean dose to such volume is 1%, providing only minor contribution
to the overall uncertainty.
The estimated overall uncertainty of the fetal dose was 30% with
the fetal segmentation uncertainty, and 15% without the fetal seg-
mentation uncertainty. The relative dosimetric effect of the fetal seg-
mentation uncertainty is based on the variability of the dose
distribution within the uterine volume which is demonstrated by the
interquartile dose ranges in the box-and-whisker plots of the Fig. 4. This
provides the reasonable boundaries for the use of uterine dose as the
surrogate of the fetal dose. The relative differences in the fetal dose
uncertainty due to segmentation were higher in the pulmonary angio-
graphy scan where the scattered radiation is directed caudally towards
the fetus from the chest volume of the mother. In the abdomino-pelvic
and trauma scans, the relative difference between mean intrauterine
dose and third quartile intrauterine dose was smaller in the early
pregnancy (about 10%) and increased towards the late pregnancy
(about 20–25%). General estimated uncertainty of 25% from the fetal
Fig. 3. Integral dose volume histograms in different pregnancy stages in trauma, low-dose abdomino-pelvic (Abd.) and pulmonary angiography (PA) CT protocols. Dose volume
histograms were determined for both intrauterine volume (dashed line) and uterine wall volume (solid line).
Fig. 4. Box-and-whisker plots presenting the 2nd and 98th percentile,
the first and third quartiles and median values of the intrauterine dose
distributions in the four modelled pregnancy stages for the three CT
protocols.
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dose due to segmentation effect was used in the net uncertainty eva-
luation. The other uncertainty factors included spectral and bowtie
modeling uncertainties [20], CTDI-calibration uncertainty [22,23],
modeling of the mA-modulation and tube start angle, and MC simula-
tion statistical uncertainty with the used photon counts (see Section 4),
providing a combined 15% uncertainty.
4. Discussion
CT imaging of a pregnant woman is sometimes necessary due to
potential and serious health risks either to the mother or the unborn
child. The pregnancy might also be unknown at the time of the ex-
amination. The most common indications for the CT examination
during pregnancy are suspected pulmonary embolism, suspected ap-
pendicitis, and trauma [3]. These three indications are also covered in a
recent review article about the clinical perspective on diagnostic X-ray
examinations of pregnant patients [24]. When the scan is appropriately
justified and needed, the benefits of the CT scan outweigh the small
radiation risk to the fetus. The radiation exposure to the fetus depends
significantly, among other factors, on the scan range and irradiation
geometry, and the fetus’s position relative to it. The exact position of
the fetus in the uterus vary and is unknown for the prospective dose
estimation. Therefore, the dose absorbed by the uterus can serve as a
surrogate for the dose absorbed by the embryo or fetus in medical ra-
diation dosimetry. In addition to these assumptions, patient specific
TCM can cause differences in the absorbed doses even when the model
and the patient match roughly in size [14]. There are also differences
between TCM techniques used by different vendors. The aim of this
study was to determine absorbed fetal doses for the most common CT
indications during pregnancy by using MC simulations and MOSFET
measurements in order to validate the MC package used for the
phantom geometries of this study. For this purpose, MC simulations
were performed for an anthropomorphic female phantom containing
different sized spherical segment boluses on the phantom’s abdomen to
simulate different stages of pregnancy. The results of this study
strengthen the knowledge about fetal doses in CT examinations, and
fetal dose comparisons that can be done between CT scanners from
different vendors are also important.
The simulated mean intrauterine doses in different stages of preg-
nancy varied from 0.04 to 1.04 mGy, from 4.8 to 5.8 mGy, and from 9.8
to 12.6 mGy in the CT scans for pulmonary angiography, abdomino-
pelvic and trauma CT scans, respectively. These values are in a good
correspondence with the previously published fetal doses that were
based on MOSFET measurements [19]. The small differences can be
caused by possible imperfections in the Monte Carlo parameters, such
as the energy spectra and the bowtie filter model. Other possible in-
accuracies can results from the fact that not all parameters affecting the
MC simulations are available from the manufacturer or they cannot be
known exactly, such as the central bowtie filter thickness or the starting
position of the X-ray tube. Forced intercept at the origin was chosen by
the assumption that both methods should agree at zero dose. The
method was considered to be robust when e.g. the unknown X-ray tube
starting position could affect the dosimeter point-dose values and result
in erroneous biases. The fitting functions were visually verified to agree
well with the data points. MOSFET dose values for the pulmonary an-
giography protocol were a reverse from the other two protocols: ap-
proximately half of the simulated values (see Fig. 2). However, ac-
cording to the values in Table 4, the difference between the mean
simulated doses to the intrauterine volumes and the fetal doses in
MOSFET measurements varies for different pregnancy stages. This is
due to the fact that certain sets of MOSFETs were chosen to represent
the fetal volume in different pregnancy stages, and this choice cannot
equally represent the 3D dose distribution and the resulting mean si-
mulated dose to the intrauterine volume. The correlation between doses
at single MOSFET positions and MC simulation results at the same
position was good. Moreover, the angular dependency of the MOSFETs
causes lower sensitivity at the distal tip and stem direction [25], and in
the pulmonary angiography protocol, irradiation from this direction
had a larger contribution to the total dose than in the trauma and
pulmonary angiography protocols. Nevertheless, the dose level in the
pulmonary CT angiography scan was very low. The correction factors
for trauma and abdominal protocols matched well with the CTDI body
phantom simulation vs. measurement results.
Many previous studies focus only on measurements or on simula-
tions, but there are few that combine them both [15,26,27], as was
done in this study. MC simulations can provide 3D dose distributions,
which are not possible with a discrete number of physical dosimeters.
However, the measurements and simulations should match, since the
used parameters were set to be as close to each other as possible. The
advantage of this approach is that the point dose measurement results
can be compared with the simulation results in order to give compre-
hensive results of the dose distributions. The agreement between the
CTDI measurements and CTDI simulations were in conformance with
previous MC program validations [22,23]. The results of this study also
compare reasonably well with previously published fetal dose values
[8–15]. Deviations were expected due to TCM and differences in the
scanning parameters and phantom properties. Especially the doses from
pulmonary angiography and trauma CT were found to be close to the
previously published results [8,9]. A previous study that utilized Im-
pactMC simulations in abdomino-pelvic CT examinations in early
pregnancy showed fetal doses of 0.34 to 0.79 mGy at 120 kVp when
normalized to absorbed dose in air [12]. The corresponding value of the
present study at 12 weeks of pregnancy was 0.64 mGy, which is in good
agreement with the previous study. If the CT examination is performed
with a fixed tube current [10,11], the results are not directly compar-
able with CT examinations performed with TCM. Moreover, the volume
representing the fetus may be defined differently. If the fetus is seg-
mented and the absorbed dose to the fetal tissues is determined, it is
likely to differ from the dose to the intrauterine volume, especially if
the dose distribution is inhomogeneous. It has been found that the fetal
doses in late pregnancy are higher than in early and mid-pregnancy
when performing abdomino-pelvic CT scans with TCM [13], whereas in
this study, the fetal dose remained fairly constant in all stages of
pregnancy in the abdomino-pelvic and trauma CT scans due to the
automatic TCM used. In this study, the higher doses at 20 weeks can be
explained by tube current modulation, phantom geometry and the
shape of the uterus, its position and location.
The variability range in the absorbed dose to the intrauterine vo-
lume was large, as can be seen in Figs. 3 and 4. The high variations in
the intrauterine doses in the trauma and abdomino-pelvic CT scans
were primarily caused by the rotating tube in helical imaging resulting
in “zebra” lines to the dose maps (Fig. 5A). The distance of the fetus
from the scan range had an effect on the fetal dose as observed in the
pulmonary angiography CT scan. According to the dose volume histo-
grams, the fetal dose in the pulmonary angiography CT scan was neg-
ligible in the early pregnancy but started to increase as the intrauterine
volume increased and the distance from the scanning range decreased.
In abdomino-pelvic and trauma CT scans, the uterus was in the primary
scanning range, and therefore the intrauterine dose was significantly
higher and more consistent compared to radiation exposure to in-
trauterine volume in pulmonary angiography CT scan.
The uterus was segmented based on reference volumes and the
chosen bolus shapes while the inferior edge was fixed. This choice did
not represent any individual human subject and different segmentations
would have resulted in slightly different mean absorbed doses. The
uncertainty contribution related to the uterine segmentation on the
dose determination can be seen from the box-and-whisker plots in the
Fig. 4 and by comparing the intrauterine doses to the combined in-
trauterine and uterine wall doses. The total mean uterine doses (in-
trauterine volume and uterine wall volume combined) in the pul-
monary CT angiography scans were 5%, 3%, 5% and 9% higher than
the mean intrauterine doses for the pregnancy stages 12, 20, 28 and
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38 weeks, respectively. In contrast, the dose remained more constant,
within one percent, in the abdomino-pelvic and trauma CT scan pro-
tocols. Differences were larger when comparing the intrauterine doses
to the uterine wall doses. The differential dose volume histograms of
the intrauterine volume and uterine wall doses in abdomino-pelvic scan
for the 38 weeks pregnancy stage is presented in Fig. 5B to exemplify
differences in the overall dose distributions. An upper bound of the fetal
doses in the simulated cases and chosen segmentations could be esti-
mated by investigating the mean dose in the high end of the dose his-
tograms. Assuming that the fetus accounts for 9% (12 weeks), 37%
(20 weeks), 56% (28 weeks) and 69% (38 weeks) of the intrauterine
volumes [7], the maximum theoretical fetal doses would then have
been 15.5, 7.5 and 0.8 mGy, for trauma, abdominal and pulmonary
angiography protocol, respectively.
There are limitations in this study. The intrauterine dose was as-
sumed to simulate the radiation dose absorbed to the fetus. However,
the intrauterine dose does not represent the fetal dose exactly because
the size and position of the fetus depends on the gestational age and
varies between individuals. Moreover, the uncertainties of the fetal
dose have several aspects: in early pregnancy, the embryo’s or fetus’s
cells will likely be exposed to a relatively uniform dose, but the location
of fetus in the uterus may not be known; in later stages of pregnancy,
the position of the fetus in the uterus may vary, and different organs
and tissues may no longer be exposed to the same doses. Furthermore,
the uterine segmentation and alignment modeling in this study was in
part guided by the physical boluses which might not be representative
for all clinical cases. Finally, in this study dose simulations were applied
to a single phantom model, for one scanner model and clinical protocol.
5. Conclusions
Volumetric dose distribution offered by MC simulations compared
with experimental point-dose measurements provides a comprehensive
dose assessment of the patient model including variations in different
scan protocols and pregnancy stages. MC simulations showed good
correlation with the MOSFET measurement at the measured locations.
The fetal doses were highest in the trauma CT protocol due to the longer
scan range and higher exposure parameters. The pregnancy stage did
not have a significant effect on the magnitude of the fetal doses in the
trauma or abdomino-pelvic scans. In the pulmonary angiography scan,
the fetal doses increased with pregnancy stage as the fetus was closer to
the CT scan range in the later pregnancy. However, the pulmonary CT
angiography scan represented sub-mGy fetal dose range irrespective of
the pregnancy stage. As a proper reminder for the concerned mothers,
the radiation exposure to the fetus resulting from any of the studied CT
scans should not be considered as a reason to terminate the pregnancy.
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